With increasing requests for the analysis of various specimens related to fatal and non-fatal abuse of methylenedioxymethamphetamine (ecstasy, MDMA), the toxicology laboratory of the Institute of Forensic Medicine has established protocols for the analysis of MDMA and related compounds in hair, urine, and various postmortem specimens. Analytical protocols include extraction, derivatization, and gas chromatographic-mass spectrometric analysis adapting deuterated analogs of the analytes as internal standards. Data resulting from these analyses and hereby reported include postmortem distribution of MDMA and methylenedioxyamphetamine (MDA) in heart blood, gastric content, urine, and bile specimens from 20 fatal cases; other drugs found in the heart blood from these 20 cases; and the distribution of MDMA and MDA in 25 antemortem urine and 6 hair specimens. The MDA/MDMA concentration ratio observed in a limited number of hair specimens (n = 6) are consistent and appear to be higher than those found in other specimens. Compared to other commonly abused drugs (e.g., cocaine and heroin), the "drug/metabolite" concentration ratio (MDMA/MDA) in hair is not significantly different from the ratios derived from other specimens, such as urine and blood. This observation is consistent with the relative drug/metabolite incorporation rates reported for cocaine/benzoylecgonine, tetrahydrocannabinol/tetrahydrocannabinoic acid, and MDMA/MDA.
Introduction
3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") is a ring-substituted amphetamine, patented in 1914 by the Merck Company as an appetite suppressant but never marketed. It reappeared in the early 1970s as an adjunct to psychotherapy, and it was claimed to enhance therapeutic communication and patients' self-awareness without psychotic or visual disturbances (1) . MDMA produces perceptional distortions and pronounced effects, including intensification of feelings, facilitation of self-insight, overwhelming desire to communicate, profound empathy, and euphoria (1, 2) . In 1985, the U.S. Drug Enforcement Administration (DEA) classified it as a schedule I controlled substance. In Taiwan, MDMA is classified as a schedule II controlled drug under the Statute for Narcotics Hazard Control list (3) . A typical oral street dose of "ecstasy" includes 75-150 mg of MDMA (4) . The delay before onset of action is approximately 30 min, and once it has begun, the effects are achieved rapidly and last for 4-6 h with an elimination half-life of approximately 8 h. The drug is primarily metabolized in the liver, where it undergoes N-dealkylation with 3,4-methylenedioxyamphetamine (MDA) as the major metabolite. Approximately 65% of MDMA is excreted unchanged in the urine (5) .
Taiwan has, in recent years, experienced a very significant increase in the abuse of MDMA. MDMA, ketamine, and gamma-hydroxybutyric acid (GHB) have gained popularity among the "club" scene and at "raves" in Taiwan (6) . Requests for the analysis of post-and antemortem specimens related to fatal and non-fatal abuse of MDMA received by the Institute of Forensic Medicine have also significantly increased. Protocols for the analysis of MDMA and related compounds in hair, urine, and various postmortem specimens have been established and hereby reported. Analytical data hereby reported include postmortem distribution of MDMA and MDA in heart blood, gastric content, urine, and bile from 20 MDMA-induced (or related) fatal cases; the distribution of MDMA and MDA in 25 antemortem urine and 6 hair specimens; and other drugs found in the heart blood from the 20 fatal cases.
Materials and Methods

Standards, reagents, chemicals, and specimens
All solvents and reagents were high-performance liquid chromatography (HPLC) grade and were purchased from J.T. Baker (Phillipsburg, NJ). Heptafluorobutyric anhydride (HFBA) was obtained from Aldrich Chemical (Milwaukee, WI). MDA, MDA-ds, MDMA, and MDMA-d5 were obtained from Cerilliant (Austin, TX). Hair samples obtained from laboratory personnel and found to be drug-flee were used for preparing standards and controls.
Twenty sets of postmortem specimens received by the Institute of Forensic Medicine were included in this study. Most of these sets included heart blood, gastric content, urine, and bile specimens, but one or two specimens (typically bile or urine) were missing in others. Six antemortem hair specimens came from two high-profile criminal cases involving drugs. Twenty urine samples from alleged MDMA abusers were also used for this study.
Sample preparation
Hair samples, each weighing at least 75 mg, were carefully cut into small segments (less than 5 ram), placed into a beaker, and decontaminated. The decontamination procedure involved three consecutive l-rain rinses with 1 mL methanol. The solvent was then evaporated at 50~ under a slow stream of nitrogen.
Test specimens, standards, and controls were prepared by first spiking 50 mg of cut and decontaminated hair with 50 iaL of a mixture of two internal standards (10 l~g/mL each of MDAd5 and MDMA-ds). Samples were then digested in 2 mL 2N NaOH at 80~ for 1 h. The resulting solution was cooled to room temperature and extracted with 5 mL ethyl acetate on a horizontal shaker for 5 rain. The mixture was then centrifuged for 5 min, and the upper ethyl acetate phase was transferred to a clean screw-cap test tube. Two milliliters of 0.5N HCI was added, and the mixture was shaken for 5 rain. After centrifugation, the acidic layer was transferred and made basic with 1 mL 2N NaOH. pH paper was used to check its basicity (pH > 9) before it was extracted with 5 mL ethyl acetate for 5 rain.
After centrifugation, the upper ethyl acetate phase was transferred to a clean screw-top tube containing 50 laL rnethanol/HC1 mixture (20 mL methanol + 0.1 mL concentrated HC1) and evaporated to dryness under a stream of nitrogen at 60~ Aliquots (2 mL) of biological fluid samples (blood, gastric, bile, and urine) were spiked with 50 laL of a mixture of two internal standards (20 lag/mL each of MDA-d5 and MDMA-ds), and I mL 2N NaOH, followed by extraction with 5 mL ethyl acetate on a horizontal shaker for 5 rain. The same procedure used for the assay hair samples was then followed.
For derivatization, 50 tJL ethyl acetate and 50 laL HFBA were added to the remaining residue following the evaporation step. Capped tubes were vortex mixed for 20 s and then heated at 70~ for 30 min. The reaction mixture was evaporated to dryness under a stream of nitrogen at 50~ and reconstituted with ethyl acetate (typically 100 I~L) prior to gas chromatographic-mass spectrometric (GC-MS) analysis.
GC-MS analysis
An Agilent 6890N GC-5973N mass selective detector, operated at 70 eV with ion source temperature of 230~ was used in this study. The GC was equipped with a 30-m HewlettPackard (Andover, MA) HP-1MS fused silica capillary column (0.25-ram i.d., 0.25-1am film thickness). The injector and interface temperature were maintained at 260 and 280~ respectively. The inlet pressure was held at 5 psi for 1 rain, then programmed to 20 psi at 2 psi/rain, and held for 4.5 rain. Oven temperature was held at 60~ for 1 rain, then programmed to 300~ at 20~ and held at the final temperature for 1 rain. The following parameters were used for injecting samples into the GC-MS system: sample size, 1 IJL; injection mode, splitless; and injector purge-off duration, 1 min.
Ions selected for monitoring the resulting HFB-derivatives were m/z 162, 240, and 375 for MDA; m/z 167, 244, and 380 for MDA-d5; m/z 254, 210, and 162 for MDMA; and m/z 258, 213, and 164 for MDMA-ds. The first ion listed for each compound was used for quantitation using five-point calibrators at 100, 250, 500, 1000, and 2000 ng/mL for urine, gastric, blood, and bile and at 2, 5, 10, 20, and 40 ng/mg for hair specimens. * If one of the specimens was found to be negative, the detection limit was used as the lower end of the range. The concentration of this specimen was then considered to be 0.0 when calculating the mean. t Antemortem specimens. 
Results and Discussion
Distribution of MDMA and MDA in postmortem and antemortem specimens Data resulting from these analyses and hereby reported include postmortem distribution of MDMA and MDA in heart blood, gastric content, urine, and bile specimens from 20 fatal cases; other drugs found in the heart blood from these 20 cases; and the distributions of MDMA and MDA in 25 antemortem urine and six hair specimens. Data summarized in Table I were compared to those reported in the literature (7-13) and discussed.
Postmortem specimens--heart blood, gastric, urine, and bile. Distribution data of MDMA and MDA in heart blood, gastric, urine, and bile specimens from 20 MDMA-induced (or related) fatal cases tested in this laboratory are listed in Table II . The type of drug found in gastric is probably a reflection of the type of drug ingested. For example, in cases 10 and 13, in which MDMA was not detected, MDA was probably ingested. Some statistical data of the findings from these 20 cases are listed in Table I . The MDA/MDMA ratios observed in urine, bile, gastric, and heart blood specimens are not significantly different.
Antemortem specimens--hair. Distribution data of MDMA and MDA in antemortem hair samples collected from six individuals are shown in Table III . MDA/MDMA ratios derived from this limited number of specimens (n = 6) are consistent within this population and appear to be higher than the corresponding ratios derived from other biological matrices, which were not collected from these subjects (other type of specimens from these subjects was not availably for comparison). This is not consistent with an animal (rats) study (12, 14) , in which MDMA's incorporation rate into hair was found higher than MDA.
Antemortem specimens--urine. Distribution data of MDMA and MDA in 25 antemortem urine case samples are shown in Table IV . Data derived from cases 15, 20, and 21 are not included in calculating the statistical information shown in Table  I . Interpretation of the data suggest that both MDA and MDMA were ingested in cases 15 and 21. MDA/MDMA ratios shown in Table IV and summarized in Table I are comparable with what have been reported in the literature (7-13).
Characteristics of "metabolite/parent drug" concentration ratios in various biological matrices MDA/MDMA ratios observed among various biological matrices. MDA/MDMA ratios derived from a limited number (n = 6) of hair specimens are consistent within this small population group and appear to be higher than those derived from other biological matrices (see Table I ). There have been a number of animal studies (rat) on the rates of incorporating various drugs into hair. In these studies, incorporation rate was defined as [HI/AUC (area under the curve), where [H] was the drug/metabolite concentration in hair; for AUC, the concentration of drug/metabolite in plasma was plotted against various time points at which the specimens were collected following the administration of the drug. These studies have reported that incorporation rate of MDMA was higher than MDA--2.3 and 1.2 times higher in the two studies reported by the same research group (12, 15) . If this is also true in hu-mans, one would expect to see a lower MDA/MDMA ratio in hair than the ratios derived from other biological matrices.
Comparison of MDA/MDMA ratio to "metabolite/parent drug" concentration ratios observed for other drug categories, such as cocaine, heroin, and methamphetamine. Animal studies (rats) have reported much higher incorporation rates of cocaine over benzoylecgonine (1200-fold higher) and 6- acetylmorphine over morphine (7-fold higher) (14) ; thus, benzoylecgonine/cocaine and morphine/6-acetylmorphine ratios in hair are expected to be much lower than the corresponding ratios derived from other biological matrices. These predictions have been proven true by actual observations. Because the difference between the incorporation rates of MDA and MDMA into hair is much less (2.3 or 1.2 times), the difference in the MDA/MDMA ratios between hair and other biological matrices is expected to be less significant. This is consistent with the observation hereby reported.
Conclusions
High levels of MDMA found in the postmortem specimens are helpful to medical examiners for making cause-of-death decisions. For example, the highest MDMA concentrations observed in heart blood, gastric, bile, and urine specimens are 40.41, 40.52, 130.95, and 67.12 IJg/mL, respectively. The prevalence of ketamine observed in these postmortem specimens is a unique finding and is in consistent with the popularity of this drug in Taiwan as reported by other epidemiological study (6) conducted to the local population. MDA/MDMA ratios observed in hair appear to be slightly higher than the ratios derived from other biological specimens. The difference between the MDA/MDMA ratios in hair and other biological matrices is much less significant than the "metabolite/parent drug" ratio differences observed for drug categories such as cocaine, heroin, and marijuana.
